A detailed history of Exchange Traded Concepts, LLC transactions in Foghorn Therapeutics Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 35,921 shares of FHTX stock, worth $336,220. This represents 0.01% of its overall portfolio holdings.

Number of Shares
35,921
Previous 47,097 23.73%
Holding current value
$336,220
Previous $316,000 34.81%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.05 - $8.0 $56,438 - $89,408
-11,176 Reduced 23.73%
35,921 $206,000
Q1 2024

Apr 15, 2024

BUY
$2.82 - $7.94 $72,084 - $202,962
25,562 Added 118.7%
47,097 $316,000
Q4 2023

Jan 05, 2024

BUY
$2.94 - $6.76 $16,052 - $36,909
5,460 Added 33.97%
21,535 $138,000
Q3 2023

Oct 18, 2023

SELL
$5.0 - $9.87 $1,980 - $3,908
-396 Reduced 2.4%
16,075 $80,000
Q2 2023

Jul 20, 2023

BUY
$5.37 - $8.84 $88,449 - $145,603
16,471 New
16,471 $115,000

Others Institutions Holding FHTX

About Foghorn Therapeutics Inc.


  • Ticker FHTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,637,400
  • Market Cap $390M
  • Description
  • Foghorn Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines targeting genetically determined dependencies within the chromatin regulatory system. The company uses its proprietary Gene Traffic Control platform to identify, validate, and potentially drug targets within the system. It is developing FHD-28...
More about FHTX
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.